All In Biotech

Drug Trial Radar · NCT07951749

Evaluating Efficacy and Safety of Berotralstat in Preventing Angioedema Attacks in Subjects With Acquired Angioedema Due to C1 Inhibitor Deficiency (AAE)

An Open Label, Single Arm, Explorative Trial to Evaluate Efficacy and Safety of Berotralstat in Preventing Angioedema Attacks in Subjects With Acquired Angioedema Due to C1 Inhibitor Deficiency (AAE)

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

16

Planned (sponsor's estimate)

Start

Nov 15, 2026

Primary completion

Dec 31, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
IRCCS Policlinico S. DonatoAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 20, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary aim of the study is to explore the effectiveness of Berotralstat in preventing angioedema attacks in patients with Acquired Angioedema (AAE-C1-INH).

Conditions

  • Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)

Interventions

  • BerotralstatDrug

    Patients will receive capsules of oral Berotralstat for 24 weeks until the end of the study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Berotralstat EffectivenessTime frame: Up to 24 weeks.

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • A.O. "Ospedali Riuniti Villa Sofia-Cervello"

    Palermo, Italy

  • Ospedale Luigi Sacco

    Milan, Milan, Italy

  • IRCCS Policlinico San Donato

    San Donato Milanese, Milan, Italy

  • Università degli Studi di Napoli Federico II

    Naples, Naples, Italy

  • Azienda Ospedale-Università di Padova

    Padova, Padua, Italy

  • Fondazione PTV Policlinico Tor Vergata

    Roma, Rome, Italy

  • AO Ordine Mauriziano di Torino

    Torino, Turin, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.